Short-read Sequencing Market Size & Growth Forecast 2026–2035, By Segments (Product, Workflow, Application, End-Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Short-read Sequencing Market size was around USD 8.31 Billion in 2025 and is slated to grow at a 18.3% CAGR from 2026 to 2035, surpassing USD 44.61 Billion by 2035. The industry revenue for 2026 is calculated at USD 9.67 billion.
Get more details on this report
Request Free Sample ReportShort-read Sequencing Market Intelligence Snapshot
Regional Market Dynamics
- North America held 52.79% of the market in 2025, supported by established genomic research infrastructure, leading sequencing manufacturers, and strong adoption across clinical research, diagnostics, and precision medicine programs.
- Asia Pacific is projected to grow at a 20.5% CAGR as genomics infrastructure expands, laboratory capacity increases, and sequencing adoption accelerates across healthcare, disease research, and large-scale genomics projects.
Segment Momentum
- Consumables represented 60.77% of the market in 2025 because every sequencing run requires recurring purchases of reagents, kits, library preparation materials, and flow cells, creating sustained demand.
- Data Analysis is the fastest-growing workflow segment as rising sequencing volumes increase demand for efficient interpretation of complex datasets and faster generation of actionable research results.
Market Expansion Drivers
- Rising demand for personalized medicine and companion diagnostics accelerating genomic testing adoption.
- Cost-effective high-throughput sequencing enabling large-scale genomic research expansion.
- Expansion of multi-omics and single-cell sequencing workflows enhancing research applications.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top players in the short-read sequencing market include Illumina, Inc. (United States), Thermo Fisher Scientific Inc. (United States), BGI Genomics Co., Ltd. (China), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Revvity, Inc. (United States), Azenta, Inc. (United States), Psomagen, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As treatment selection becomes more tightly linked to molecular profiling, laboratories and clinical testing networks are expanding their use of platforms that can process large volumes of targeted and whole-genome samples with consistent accuracy. This is strengthening demand for the short-read sequencing market because short-read systems are well suited to detecting the variants most commonly used in oncology panels, inherited disease screening, reproductive testing, and therapy-matching workflows. The push from drug developers to pair therapeutics with validated biomarkers also reinforces adoption, since companion diagnostics require scalable, standardized sequencing pipelines that can support assay development, clinical validation, and routine testing once products reach care settings.
Cost-effective high-throughput sequencing enabling large-scale genomic research expansion
The economics of processing thousands of samples in parallel remain a central reason institutions continue to scale sequencing programs, particularly in population genomics, biobank initiatives, translational research, and public health surveillance. In the short-read sequencing market, cost-efficient high-throughput workflows make it practical for research organizations to broaden cohort sizes, repeat analyses across time points, and generate statistically robust datasets without proportionally increasing per-sample expense. That purchasing behavior supports market expansion not only for core sequencing instruments, but also for library preparation kits, consumables, and bioinformatics pipelines built around high-volume, repeatable sequencing runs.
Expansion of multi-omics and single-cell sequencing workflows enhancing research applications
Research priorities are shifting from bulk genomic reads alone toward integrated datasets that connect DNA, RNA, epigenetic markers, and cell-level heterogeneity, which is increasing the operational relevance of sequencing platforms that can feed these workflows reliably. The short-read sequencing market benefits because many multi-omics and single-cell protocols depend on short-read output for high-depth, parallel analysis of complex samples, especially in cancer biology, immunology, and developmental research. As laboratories adopt these applications, sequencing demand becomes less episodic and more embedded in broader experimental design, influencing market adoption through recurring reagent use, workflow standardization, and deeper integration with specialized sample preparation and analysis tools.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding clinical genomics & oncology research adoption | 7.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Growth in personalized medicine & precision diagnostics | 6.20% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | High | Moderate |
| Advances in NGS throughput & cost reduction | 5.10% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Rising demand for personalized medicine and companion diagnostics accelerating genomic testing adoption | 2.40% | High | North America, Europe, Asia Pacific | High | Near Term |
| Cost-effective high-throughput sequencing enabling large-scale genomic research expansion | 1.90% | Moderate | North America, Europe | High | Mid Term |
| Expansion of multi-omics and single-cell sequencing workflows enhancing research applications | 1.60% | Moderate | North America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 52.79% share of the short-read sequencing market in 2025, supported by its concentrated base of sequencing platform manufacturers, established genomic research infrastructure, and broad integration of sequencing into clinical research and diagnostic workflows. The region’s leadership is strengthened by high testing volumes across academic centers, pharmaceutical development programs, and precision medicine initiatives, where short-read platforms are routinely used for applications such as variant detection, biomarker discovery, and population-scale studies. This mature operating environment sustains demand for instruments, consumables, and data analysis services through recurring use rather than one-time adoption.
Asia Pacific is advancing at a 20.5% CAGR over the forecast period in the short-read sequencing market, driven by expanding genomics capacity, rising research activity, and wider adoption of sequencing in healthcare and life sciences settings. Growth is being impelled by the buildout of laboratory infrastructure and increased use of sequencing in disease research, clinical investigation, and large-scale genomics projects, which is translating into higher instrument placements and consumables demand. As more institutions move from pilot programs to routine sequencing workflows, adoption is accelerating through practical increases in sample throughput and broader access to sequencing capabilities across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Translational Genomics FocusGermany emphasizes short-read sequencing for clinical research, molecular diagnostics, and academic collaborations. Research institutions increasingly strengthen sequencing capabilities to support biomarker discovery and standardized genomic analysis workflows.
France 🇫🇷
Clinical Genomics DevelopmentFrance continues integrating short-read sequencing into healthcare research and clinical genomics programs. Research organizations increasingly focus on scalable sequencing platforms that support molecular diagnostics, population studies, and translational research initiatives.
Italy 🇮🇹
Academic Sequencing CapacityItaly is expanding the use of short-read sequencing through research institutions, hospitals, and collaborative genomics projects. Italian laboratories increasingly prioritize efficient sequencing workflows that support clinical research and advanced molecular analysis.
Japan 🇯🇵
Precision Diagnostics IntegrationJapan continues expanding short-read sequencing applications across healthcare and life sciences research. Japanese laboratories prioritize reliable sequencing technologies that deliver consistent performance for clinical genomics and disease-focused research programs.
South Korea 🇰🇷
Biotechnology Research SupportSouth Korea is strengthening short-read sequencing capabilities through growing biotechnology investment and genomic research initiatives. Laboratories increasingly adopt automated sequencing workflows that improve throughput and support precision medicine applications.
United States 🇺🇸
Genomic Research ExpansionThe U.S. short-read sequencing market benefits from sustained investment in clinical genomics, biomedical research, and precision medicine initiatives. Laboratories increasingly adopt high-throughput sequencing platforms that improve scalability, analytical accuracy, and workflow efficiency.
Segment Leadership and Growth Trends
Short-read Sequencing Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportConsumables held a 60.77% share of the short-read sequencing market in 2025, reflecting their central role in routine sequencing operations across research and clinical laboratories. This segment maintains leadership because every sequencing run depends on a recurring supply of kits, reagents, library preparation materials, and flow cells, making demand closely tied to installed instrument usage rather than one-time capital purchases. In the short-read sequencing market, that repeat-purchase pattern gives consumables a durable revenue base and reinforces their leading share as testing volumes and research throughput remain active.
Services are emerging as the fastest-growing part of the short-read sequencing market as more users seek external support for sequencing execution, workflow optimization, and specialized analytical needs. Growth is being influenced by the practical advantage of accessing technical expertise and scalable capacity without building full in-house capabilities, which is especially relevant for organizations managing variable project loads or limited bioinformatics infrastructure. Compared with product-only procurement, services gain momentum because they reduce operational complexity and help users move from sample to usable output more efficiently.
Workflow Segment Analysis: Sequencing (Largest Segment) vs Data Analysis (Fastest-Growing Segment)
By 2025, sequencing accounted for a 59.47% share of the short-read sequencing market, backed by its position as the core step that generates the raw output required for every downstream application. The segment’s leadership is maintained through direct dependence on sequencing instruments and run chemistry to produce usable read data, making it the essential operational center of the workflow. In the short-read sequencing market, this foundational role keeps sequencing at the forefront of spending and workflow prioritization across laboratories.
Data Analysis is the fastest-growing workflow segment in the short-read sequencing market because rising data volumes are increasing the need to convert sequencing output into interpretable and decision-ready results. Momentum is strongest where users face growing pressure to manage complex datasets, improve turnaround, and extract reliable insights without expanding internal analytical bottlenecks. Relative to other workflow steps, data analysis is gaining faster traction because the value of sequencing increasingly depends on how effectively the resulting data can be processed, interpreted, and applied.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Instruments, Consumables, Services | Consumables | Services |
| Workflow | Pre-Sequencing, Sequencing, Data Analysis | Sequencing | Data Analysis |
| Application | Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, Others | Targeted Sequencing & Resequencing | Whole Genome Sequencing |
| End-Use | Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others | Academic & Research Institutes | Pharmaceutical & Biotechnology Companies |
Competitive Landscape and Market Positioning
1. Illumina Inc. (United States)
2. Thermo Fisher Scientific Inc. (United States)
3. BGI Genomics Co. Ltd. (China)
4. QIAGEN N.V. (Netherlands)
5. Agilent Technologies Inc. (United States)
6. Revvity Inc. (United States)
7. Azenta Inc. (United States)
8. Psomagen Inc. (United States)
9. F. Hoffmann-La Roche Ltd. (Switzerland)
The short-read sequencing market is expanding with strong momentum in genomic research and clinical diagnostics applications. Improvements in sequencing speed, accuracy, and computational analysis are driving broader adoption across research ecosystems. Continuous technological upgrades and integrated bioinformatics solutions are enabling more efficient genomic interpretation, while collaborative research initiatives are accelerating innovation cycles.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Element Biosciences | Feb-26 | Element Biosciences introduced the VITARI sequencing system, a high-throughput benchtop platform designed to approach the $100 whole-genome sequencing threshold. The system significantly reduces sequencing costs while improving scalability and accessibility, intensifying competitive pressure in the short-read sequencing market through lower-cost genomic throughput and expanded adoption potential. |
| PacBio | May-26 | PacBio reported its Q1 2026 financial results for the quarter ended March 31, 2026, providing insights into revenue performance and commercial traction of its sequencing platforms. The update reflects broader adoption trends and competitive positioning within the genomics sequencing market, offering visibility into operational momentum and market demand dynamics. |
| Illumina | Sep-25 | Illumina launched Illumina Protein Prep, an assay enabling next-generation sequencing-based proteomics research. The solution integrates proteomics with large-scale genomics studies across oncology, cardiometabolic, and immunologic applications, expanding Illumina’s platform utility and strengthening its position in multi-omics workflows within the sequencing ecosystem. |
| QIAGEN | Jul-25 | QIAGEN introduced QIAseq xHYB Long Read Panels, a targeted enrichment solution designed to support long-read sequencing of complex genomic regions. The panels are optimized for compatibility with native long-read platforms such as PacBio, improving detection of diverse genomic variants and enhancing QIAGEN’s role in enabling advanced sequencing workflows. |
| Roche | Feb-25 | Roche launched its sequencing by expansion (SBX) technology, a proprietary next-generation sequencing method paired with a sensor module. The system is designed to enable rapid and scalable sequencing across applications, strengthening Roche’s competitive positioning in sequencing technology through a differentiated chemistry approach. |
| PacBio | Aug-23 | PacBio began commercializing the Onso short-read sequencing system in the United States, leveraging sequencing-by-binding (SBB) chemistry. The platform is designed to deliver high accuracy in a benchtop format, supporting broader adoption of short-read sequencing and enhancing PacBio’s competitive presence in the next-generation sequencing market. |
| Illumina | Dec-23 | Firalis Molecular Precision expanded its genomics capabilities by acquiring Illumina’s NovaSeq X Plus Sequencing System. The platform enables dual flow cell sequencing, improving throughput and scalability of short-read sequencing operations and supporting increased capacity for large-scale genomic research and commercial applications. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Short-read Sequencing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Short-read Sequencing Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the short-read sequencing market?
How much is the short-read sequencing industry expected to grow by 2035?
How is the shift toward outsourced sequencing services changing operational models in genomics workflows?
What is driving the increasing strategic importance of data analysis within short-read sequencing workflows?
Why do consumables account for the largest share of the short-read sequencing market?
Which workflow segment is growing fastest in the short-read sequencing market?
Why does North America lead the short-read sequencing market?
What is driving rapid growth in the Asia Pacific short-read sequencing market?
Which companies are driving growth in the short-read sequencing landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization